사립체매개성세포사멸 억제를 통한 prostaglandin E2의 7-ketocholesterol 유발 세포독성 보호효과

키워드

참고문헌 (38)

1. Simonian NA, "Oxidative stress in neurodegenerative diseases", Annu Rev Pharmacol Toxicol, 36, pp.83~106 (1996)
2. Jenner P, "Oxidative stress in Parkinson’s disease", Ann Neurol, 53(3), pp.S26~S38 (2003)
3. Olanow CW, "Etiology and pathogenesis of Parkinson’s disease", Annu Rev Neurosci, 22, pp.123~144 (1999)
4. Ross R, "The pathogenesis of atherosclerosis: a perspective for the 1990s", Nature, 362, pp.801~809 (1993)
5. Draczynska-Luisiak B, "Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease", Mol Chem Neuropathol, 33, pp.139~148 (1998)
6. Keller JN, "Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases", J Neurochem, 72, pp.2601~2609 (1999)
7. Vejux A, "Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis", Braz J Med Biol Res, 41, pp.545~556 (2008)
8. Miguet-Alfonsi C, "Analysis of oxidative processes and of myelin figures formation before and after the loss of the mitochondrial transmembrane potential during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: comparison with various pro-apoptotic chemicals", Biochem Pharmacol, 64, pp.527~541 (2002)
9. Lee CS, "Differential modulation of 7-ketocholesterol toxicity against PC12 cells by calmodulin antagonists and Ca2+ channel blockers", Neurochem Res, 32, pp.87~98 (2007)
10. Narumiya S, "Prostanoid receptors: structures, properties, and functions", Physiol Rev, 79, pp.1193~1226 (1999)
11. Echeverria V, "Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure", Eur J Neurosci, 22, pp.2199~2206 (2005)
12. McCullough L, "Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia", J Neurosci, 24, pp.257~268 (2004)
13. Liou JY, "Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosis", Stem Cells, 25, pp.1096~1103 (2007)
14. Li W, "Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2α exacerbate hypoxic neuronal injury in neuron-enriched primary culture", Neurochem Res, 33, pp.490~499 (2008)
15. Takadera T, "Prostaglandin E2 deteriorates N-methyl-Daspartate receptor-mediated cytotoxicity possibly by activating EP2 receptors in cultured cortical neurons", Life Sci, 78, pp.1878~1883 (2006)
16. Takadera T, "Prostaglandin E2 induced caspasedependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons", Neurochem Int, 45, pp.713~719 (2004)
17. Ahmad M, "Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury", J Neuroimmunol, 184, pp.172~179 (2007)
18. Bjorkhem I, "Diczfalusy U. Oxysetrols and Alzheimer’s disease", Acta Neurol Scand Suppl, 185, pp.43~49 (2006)
19. Bonuccelli U, "New pharmacological horizons in the treatment of Parkinson disease", Neurology, 67(7), pp.S30~S38 (2006)
20. Tatton WG, "Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells", J Pharmacol Exp Ther, 301, pp.753~764 (2002)
21. Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
22. Berthier A, "Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis", Cell Death Differ, 11, pp.897~905 (2004)
23. Greene LA, "Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor", Proc Natl Acad Sci U S A, 73, pp.2424~2428 (1976)
24. Kadota T, "Expression of dopamine transporter at the tips of growing neurites of PC12 cells", J Histochem Cytochem, 44, pp.989~996 (1996)
25. Das KP, "Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures", Neurotoxicol Teratol, 26, pp.397~406 (2004)
26. Rong P, "Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes", J Neurochem, 72, pp.2294~2300 (1999)
27. Kim YJ, "7-Ketocholesterol enhances 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells", J Neural Transm, 113, pp.1877~1885 (2006)
28. Youdim MB, "Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax", Neuropharmacology, 46, pp.1130~1140 (2004)
29. Camins A, "Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches", Methods Find Exp Clin Pharmacol, 30, pp.43~65 (2008)
30. Sakamoto A, "A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production", Shock, 22, pp.76~81 (2004)
31. Foller M, "PGE2-induced apoptotic cell death in K562 human leukaemia cells", Cell Physiol Biochem, 17, pp.201~210 (2006)
32. Culmsee C, "p53 in neuronal apoptosis", Biochem Biophys Res Commun, 331, pp.761~777 (2005)
33. Perier C, "Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson’s disease", Proc Natl Acad Sci U S A, 104, pp.8161~8166 (2007)
34. is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells, "J Neurochem", 2008, 2404~2417
35. Nair VD, "Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease", Apoptosis, 11, pp.955~966 (2006)
36. Mandir AS, "A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism", J Neurochem, 83, pp.186~192 (2002)
37. Martínez M, "Hypothesis: can N-acetylcysteine be beneficial in Parkinson’s disease?", Life Sci, 64, pp.1253~1257 (1999)
38. Chipuk JE, "Dissecting p53-dependent apoptosis", Cell Death Differ, 13, pp.994~1002 (2006)

관련 논문AI추천